Chatham Rock Phosphate's ordinary shares have been placed on a trading halt by NZ RegCo. The halt took effect at 2:59pm on Thursday and was applied pending Chatham Rock's compliance with a request for more information from NZ RegCo. The halt will remain in place until Chatham Rock makes an announcement or until the market opens on Monday.
No further details were provided.
See more
Auckland surgical products company is forecasting annual profit of between $2m to $6m.
The cancer diagnostics company is awaiting outcomes of several events.
Blis has reported an increase in revenue and earnings despite a patent dispute.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details
